Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
Charalampos Charalampous(The Ohio State University Wexner Medical Center), Taxiarchis Kourelis
Cited by 31
Related Papers
Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death
|Blood|2017|340
Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
|Blood Cancer Journal|2018|288
Energy Management and Control of a Flywheel Storage System for Peak Shaving Applications
|IEEE Transactions on Smart Grid|2021|80
Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis
|Cancer Research Communications|2022|40